|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$522,000
|
N/A
|
National Institutes of Health
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$34,843
|
N/A
|
DCEG (NCI)
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$12,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$6,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$11,865
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$19,954
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$379,272
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
|
5R01CA201247-02
|
$542,767
|
$542,767
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$591,339
|
$591,339
|
Acharya, Jairaj
|
CCR (NCI)
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$466,829
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$7,553,284
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells
|
5F31CA196330-02
|
$29,728
|
$29,728
|
ADANE, BINIAM
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
|
1K22CA218467-01
|
$192,575
|
$192,575
|
ADORO, STANLEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$6,198
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$29,488
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
SON-mediated gene expression and leukemia
|
5R01CA190688-02
|
$346,556
|
$346,556
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
|
|
The cohesin complex as a tumor suppressor in myeloid leukemia
|
1R01CA216421-01
|
$536,993
|
$536,993
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-09
|
$381,375
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-04
|
$355,993
|
$355,993
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-03
|
$457,533
|
$457,533
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-02
|
$462,880
|
$462,880
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
7R50CA211533-02
|
$122,475
|
$122,475
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$54,714
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
|
5R01CA204639-02
|
$701,584
|
$701,584
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-03
|
$362,569
|
$362,569
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$762,737
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$791,415
|
$791,415
|
Anderson, Stephen
|
CCR (NCI)
|
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$443,718
|
$443,718
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$380,330
|
$380,330
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$380,330
|
$190,165
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$63,388
|
$31,694
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-02
|
$500,397
|
$500,397
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$723,348
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-09
|
$538,819
|
$538,819
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$5,250
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$74,400
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$676,540
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$12,500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$6,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-04
|
$257,562
|
$257,562
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
Personalized vaccine for patients with AML
|
1R01CA212649-01
|
$739,429
|
$739,429
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-08
|
$343,388
|
$343,388
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
Total relevant funding to Leukemia for this search: $250,547,507
|
